quantitative
Analysis v1
Strong Support
For people with heart disease who are already taking cholesterol-lowering pills, adding a drug called evolocumab can slash their bad cholesterol by about 60% in less than a year—bringing it down to very low levels.
74
0
Evidence from Studies
Supporting (1)
74
Community contributions welcome
74
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
Randomized Controlled Trial
Human
2017 May 4The study tested adding evolocumab to statins in heart disease patients and found it lowered bad cholesterol by 59%, just as claimed.
Contradicting (0)
0
Community contributions welcome
No contradicting evidence found
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.